Table 4.
Microbiologically documented infections observed during therapy (N = 29)
| Organism | n (%) |
|---|---|
| Sterile site bacteria* |
|
| Gram positive |
13 (44.8) |
| Viridans group streptococci |
6 (20.7) |
| Coagulase negative staphylococci |
5 (17.2) |
| Enterococcus faecalis |
1 (3.4) |
| Mycoplasma pneumoniae |
1 (3.4) |
| Gram Negative |
4 (13.8) |
| Escherichia coli |
2 (7.0) |
| Klebsiella pneumoniae |
1 (3.4) |
| Enterobacter cloacae |
1 (3.4) |
| Fungus* |
3 (10.3) |
| Candida albicans |
2 (7.0) |
| Alternaria NOS |
1 (3.4) |
| Virus* |
9 (31.0) |
| Herpes simplex virus |
2 (7.0) |
| Respiratory syncytial virus |
1 (3.4) |
| Torovirus |
4 (13.8) |
| Other1 | 2 (7.0) |
Abbreviation: NOS not otherwise specified;
* For bacterial infections, only sterile site positive cultures are shown. For fungi and viruses, both sterile and non-sterile site positive cultures are shown;
1 Others were adenovirus (n = 1) and influenza A (n = 1).